Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,361 | -33,005 | -110,218 | -78,538 | -49,557 |
| Depreciation Amortization | 1,814 | 893 | 1,253 | 417 | 165 |
| Accounts payable and accrued liabilities | -571 | 575 | -1,045 | -4,079 | -1,564 |
| Other Working Capital | -1,889 | -3,593 | -2 | -5,829 | -8,258 |
| Other Operating Activity | 5,729 | 2,219 | 11,959 | 12,277 | 6,997 |
| Operating Cash Flow | $-56,278 | $-32,911 | $-98,053 | $-75,752 | $-52,217 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,644 | -3,799 | -48,147 | -43,476 | -34,656 |
| Net Acquisitions | -22,174 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-27,818 | $-3,799 | $-48,147 | $-43,476 | $-34,656 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,494 | 2,465 | 94,503 | 84,870 | 57,995 |
| Common Stock Repurchased | -13,965 | -13,965 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -6,659 | -4,255 | 27,245 |
| Financing Cash Flow | $-10,471 | $-11,500 | $87,844 | $80,615 | $85,240 |
| Exchange Rate Effect | -43 | -43 | -74 | -69 | -49 |
| Beginning Cash Position | 120,470 | 120,470 | 178,900 | 178,900 | 178,900 |
| End Cash Position | 25,860 | 72,217 | 120,470 | 140,218 | 177,218 |
| Net Cash Flow | $-94,610 | $-48,253 | $-58,430 | $-38,682 | $-1,682 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,278 | -32,911 | -98,053 | -75,752 | -52,217 |
| Capital Expenditure | -5,644 | -3,799 | -48,147 | -43,476 | -34,656 |
| Free Cash Flow | -61,922 | -36,710 | -146,200 | -119,228 | -86,873 |